Top Markets
#1 Glidr Glidr +51.75%
#2 DOVU DOVU +47.62%
#3 Akedo Akedo +43.85%
#4 Velvet Velvet +39.70%
#5 Black Phoenix Black Phoenix +34.25%
#6 Cross Cross +26.33%
#7 Perle Perle +18.76%
#8 Cysic Cysic +18.58%
#9 Bitway Bitway +15.04%
#10 QANplatform QANplatform +14.82%
Coin of the day
Glidr Glidr
Pengaturan
Bahasa
BAHASA INDONESIA
Mata uang
USD
Tema
Lipidor AB (publ) Lipidor AB (publ)

Lipidor AB (publ)

LIPI
Peringkat dalam Saham #39101
Lipidor AB (publ), a Swedish pharmaceutical company founded in Danderyd in... Lipidor AB (publ), a Swedish pharmaceutical company founded in Danderyd in 2009, specializes in developing medicinal products. Its core business centers on creating treatments for various skin conditions, including psoriasis, bacterial skin infections, and atopic dermatitis. The company's product pipeline includes AKP-01, which is currently in Phase III clinical trials for psoriasis, while other formulations like AKP-02 (also for psoriasis) and AKP-03 and AKP-07 (for eczema) are in earlier, preclinical development stages. Beyond its own drug candidates, Lipidor manufactures and supplies active pharmaceutical ingredients (APIs). These APIs are incorporated into products addressing a broad spectrum of therapeutic applications, such as managing psoriasis, microbial infections, inflammation, fungal issues, local pain relief, acne, wound healing, eczema, and migraines. Lipidor also caters to the animal health market, offering a line of spray-on skin care products for dogs, cats, and horses. Additionally, it develops consumer health items designed for purposes like antibacterial action, antiseptic care, moisturizing, disinfection, and treating acne and warts. In a key strategic alliance, Lipidor has partnered with Cannassure Therapeutics Ltd. This collaboration aims to advance topical medicinal cannabis products specifically formulated to alleviate skin inflammations and psoriatic lesions.
Harga Saham
$0.02243487
Terakhir disinkronkan: 2025-06-04
Kapitalisasi Pasar
$650.09K
Perubahan (1 hari)
0.39%
Perubahan (1 tahun)
0.00%
Negara
SE
Perdagangan Lipidor AB (publ) (LIPI)

Kategori

Healthcare
Rasio P/S untuk Lipidor AB (publ) (LIPI)
Rasio P/S per August 2026 TTM: 12.49K
Menurut laporan keuangan dan harga saham terbaru dari Lipidor AB (publ), rasio P/S saat ini (TTM) adalah 12.49K. Pada akhir 2023, rasio P/S perusahaan adalah 187.24.
Riwayat rasio P/S untuk Lipidor AB (publ) dari 2016 hingga 2026
Rasio P/S pada akhir setiap tahun
Tahun Rasio P/S Mengubah
2026 (TTM) 12.49K 89.82%
2024 6.58K 3,414.61%
2023 187.24 -60.49%
2022 473.93 2,985.50%
2021 15.36 -97.13%
2020 534.79 -88.42%
2019 4.62K 822.07%
2018 501.03 35.80%
2017 368.94 -14.60%
2016 432.02 0.00%
Rasio P/S untuk perusahaan sejenis atau pesaing
Perusahaan Rasio P/S Perbedaan Rasio P/S Negara
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
14.97 -99.88%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
6.31 -99.95%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
7.06 -99.94%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
4.66 -99.96%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
4.90 -99.96%
US